Financial comparisons Syngene International Limited
Equities
SYNGENE
INE398R01022
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 466.30 INR | +2.70% |
|
-3.36% | -28.37% |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 43Cr | 13.62% | 16.78% | 11.05% | 8.11% | -1.22x | ||
| 823.63Cr | 14.53% | 21.7% | 10.28% | 4.9% | 1.58x | ||
| 534.3Cr | 5.37% | 8.37% | 29.84% | 16.27% | -5.99x | ||
| 1.63TCr | 8.34% | 13.38% | 32.9% | 4.79% | 3.63x | ||
| 288.36Cr | 24.74% | 28.07% | 5.94% | 4.75% | 1.77x | ||
| 85Cr | -31.67% | -18.92% | - | - | 1.57x | ||
| 94Cr | -40.36% | -40.47% | -70.72% | -11.67% | 4.51x | ||
| 856.64Cr | 6.51% | 14.79% | 9.61% | 4.34% | 2.22x | ||
| 253.02Cr | 17.83% | 20.93% | 70.23% | 22.13% | -0.89x | ||
| 54.01L | -7,306.52% | -5,350% | -135.58% | - | 2.1x | ||
| 828.17Cr | 9.56% | 19.29% | 12.39% | 6.87% | 1.66x | ||
| 51Cr | -13.19% | -41.67% | -31.26% | -21.6% | -0.14x | ||
| 127.18Cr | -19.27% | -3.71% | -38.64% | -6.61% | -65.61x | ||
| 401.54Cr | -3.59% | 19.77% | 15.46% | 6.99% | 1.98x | ||
| 88Cr | 21.41% | 24.07% | 10.4% | 7.38% | 0.12x | ||
| 209Cr | 20.33% | 29.46% | 17.5% | 10.73% | 0.74x | ||
| 121.96Cr | 6.02% | 31.45% | 15.37% | 11.65% | 0.43x | ||
| Average | 378.56Cr | -427.43% | -306.28% | -2.2% | 4.6% | -3.03x | |
| Weighted average by Cap. | 556.18Cr | -267.92% | -189.38% | 5.7% | 5.75% | -1.43x |
- Stock Market
- Equities
- SYNGENE Stock
- Sector Syngene International Limited
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















